PURE Bioscience, Inc. (PURE) Total liabilities 2017–2026
PURE Bioscience, Inc. (PURE) total liabilities at each fiscal year-end, per SEC filings.
$7.6MFY2026 · since FY2017: $2.5M → $7.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | $7.6M | +23.0% |
| FY2025 | $6.2M | +67.7% |
| FY2024 | $3.7M | +137.1% |
| FY2023 | $1.6M | +170.1% |
| FY2022 | $575,000 | -40.7% |
| FY2021 | $970,000 | -35.8% |
| FY2020 | $1.5M | +103.8% |
| FY2019 | $742,000 | -42.7% |
| FY2018 | $1.3M | -49.0% |
| FY2017 | $2.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More PURE financial trends
PURE RevenuePURE Net incomePURE Net marginPURE Gross profitPURE Gross marginPURE Operating incomePURE Operating marginPURE Operating cash flowPURE Free cash flowPURE Capital expendituresPURE Return on equityPURE Stock buybacksPURE Dividends paidPURE Total assetsPURE Shareholders’ equityPURE overview →